Phathom Pharmaceuticals Stock (NASDAQ:PHAT), Quotes and News Summary

Q: What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Phathom Pharmaceuticals Stock (NASDAQ: PHAT) stock price, news, charts, stock research, profile.

Open	$9.480
Close	$8.970
Volume / Avg.	590.237K / 894.370K
Day Range	8.910 - 9.880
52 Wk Range	6.065 - 17.019
Market Cap	$548.991M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	37.37%
Days to Cover	12.86

Recent News

Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.

Avi Kapoor

"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales

Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),

Nabaparna Bhattacharya

What's Going On With Phathom Pharmaceuticals Stock?

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) shares are trading higher Monday after the company announced FDA approval of its reformulated vo

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Phathom Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focu...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Phathom Pharmaceuticals (PHAT) stock?

You can purchase shares of Phathom Pharmaceuticals (NASDAQ: PHAT) through any online brokerage.

View our list of the best stock brokerages.

Who are Phathom Pharmaceuticals's (PHAT) competitors?

Other companies in Phathom Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).

What is the target price for Phathom Pharmaceuticals (PHAT) stock?

The latest price target for Phathom Pharmaceuticals (NASDAQ: PHAT) was reported by Needham on Friday, April 19, 2024. The analyst firm set a price target for 26.00 expecting PHAT to rise to within 12 months (a possible 177.17% upside). 22 analyst firms have reported ratings in the last year.

Current Stock Price for Phathom Pharmaceuticals (PHAT)?

The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $9.3806 last updated April 19, 2024 at 7:12 AM EDT.

Does Phathom Pharmaceuticals (PHAT) pay a dividend?

There are no upcoming dividends for Phathom Pharmaceuticals.

When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?

Phathom Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is Phathom Pharmaceuticals (PHAT) going to split?

There is no upcoming split for Phathom Pharmaceuticals.

What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-